Patents by Inventor Kevin Friedman

Kevin Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190194615
    Abstract: The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 27, 2019
    Applicant: bluebird bio, Inc.
    Inventor: Kevin FRIEDMAN
  • Publication number: 20190085092
    Abstract: The invention provides improved compositions for adoptive cell therapies for cancers that express the glycoepitope STn on TAG-72.
    Type: Application
    Filed: August 30, 2016
    Publication date: March 21, 2019
    Applicants: bluebird bio, Inc., ViroMed Co., LTD.
    Inventors: Richard MORGAN, Kevin FRIEDMAN, Seung Shin YU, Jae-Gyun JEONG, Jin-A CHAE
  • Publication number: 20180085444
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 29, 2018
    Inventors: Richard MORGAN, Kevin FRIEDMAN
  • Publication number: 20170226216
    Abstract: The invention provides improved compositions for adoptive T cell therapies for B cell related conditions.
    Type: Application
    Filed: July 23, 2015
    Publication date: August 10, 2017
    Inventors: Richard Morgan, Kevin Friedman
  • Publication number: 20170218337
    Abstract: The invention provides improved T cell compositions and methods for manufacturing T cells. More particularly, the invention provides methods of T cell manufacturing that result in adoptive T cell immunotherapies with improved survival, expansion, and persistence in vivo.
    Type: Application
    Filed: June 5, 2015
    Publication date: August 3, 2017
    Inventor: Kevin Friedman
  • Publication number: 20170049819
    Abstract: The invention provides improved vector composition comprising chimeric antigen receptor for adoptive T cell therapies.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 23, 2017
    Inventors: Kevin Friedman, Byoung Ryu
  • Publication number: 20170051308
    Abstract: Vector compositions comprising a myeloproliferative sarcoma virus enhancer, negative control region deleted, dl587rev primer-binding site substituted (MND) promoter operably linked to a chimeric antigen receptor (CAR) are provided.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 23, 2017
    Inventors: Richard Morgan, Kevin Friedman, Byoung Ryu
  • Publication number: 20170051252
    Abstract: The invention provides compositions and methods for manufacturing adoptive cell therapies. In particular embodiments, the invention provides methods of harvesting populations of cells, isolating and activating PBMCs, expanding T cells, and administering the T cell therapeutic to a subject in need thereof.
    Type: Application
    Filed: April 24, 2015
    Publication date: February 23, 2017
    Inventors: Richard Morgan, Kevin Friedman, Dawn Maier
  • Publication number: 20070150416
    Abstract: A specially configured payment card that functions as both a standard payment, e.g., bank credit, debit, or ATM card for use in point-of-purchase transactions and an optical storage device that can be read by any common CD or DVD drive for use in secure online E-Commerce transactions. In order to prevent copying of the data stored in the optical storage media, a code can be included in the Absolute Time In Pregroove (ATIP) area of the optical media. This code can be used in order to protect against the use of counterfeit cards in online transactions.
    Type: Application
    Filed: December 1, 2005
    Publication date: June 28, 2007
    Inventor: Kevin Friedman